Table 1.
Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | |
---|---|---|---|---|---|---|---|
Age at presentation (days) | 25 | 28 | 8 | 23 | 10 | 5 | 10 |
Symptoms | Vomiting and weight loss | Weight loss and poor feeding | Weight loss | Vomiting and weight loss | Inpatient | Jaundice and weight loss | Weight loss and drowsiness |
Plasma Na (mmol/l) (RR 135–145) | 119 | 126 | 118 | 118 | 109 | 142 (112 on D10) | 126 |
Plasma K (mmol/l) (RR 3.5–5) | NA | 6.8 | 8.2 | 7.3 | 6.8 | 6.1 (11.3 on D10) | 10 |
Plasma HCO3− (mmol/l) (RR 17–25) | 19.4 | 17.9 | 19.6 | NA | 18.6 | 19.3 (D10) | 10.4 |
pH | 7.39 | 7.27 | NA | NA | 7.27 | 7.38 | 7.21 |
Creatinine (μmol/l) (RR 37–89) | 67 | 61 | 29 | 48 | 96 | 74 (87 on D10) | 49 (D11) |
Urine K (mmol/l) | 37 | 20 | NA | 19 (24) | 10 | 22 | 7 (D15) |
Urine Na (mmol/l) | 50 | 16 | 15 | 20 (D24) | 35 | 111 | 142 (D15) |
Serum aldosterone (pmol/l) (RR 400–3000) | 35 700 | 39 900 | 83 390 | 48 000 | 49 500 | 57 000 | 16 580 |
PRA (nmol/l per h) (RR 1.9–29) | 41.3 | 250 | >250 | 16 | >250 | >250 | 131.5 |
Duration of follow-up (months) | 62 | 38 | 25 | 14 | 36 | 39 | 42 |
Weight centile at last clinic appointment | 91st–98th | 9th–25th | 25th | 50th | 91st–98th | 9th | 75th |
Ongoing management | Initial Na supplementation 2.5 mmol/kg per day | Initial Na supplementation 1.5 mmol/kg per day | Initial Na supplementation 2 mmol/kg per day | Discharged from follow-up. Not on medication | Initial Na supplementation 4 mmol/kg per day | Initial Na supplementation 3.8 mmol/kg per day* | Na supplements 8.5 mmol/kg per day* |
Now on 0.7 mmol/kg per day | Now on Na 0.7 mmol/kg per day | Now on Na 0.8 mmol/kg per day | NaHCO3 1.6 mmol/kg per day* | NaHCO3 2 mmol/kg per day* | |||
Indomethacin 1.5 mg/kg b.d. | Flucloxacillin 125 mg b.d. | ||||||
Gaviscon | Penicillin V 125 mg b.d. | ||||||
Ranitidine | Omeprazole 0.6 mg/kg b.d. | ||||||
Low potassium feeds | Domperidone 0.35 mg/kg b.d. | ||||||
Intermittent requirement for i.v. 0.9% NaCl | Montelukast 4 mg o.d. | ||||||
Beclometasone 200 μg b.d. | |||||||
Sodium cromoglycate 5 mg q.d.s. | |||||||
Low potassium feeds | |||||||
PRA (nmol/l per h) after long-term management | 6.1 | 24.9 | NA | 7.4 | 1.1 | 0.3 | Not done |
Aldosterone (pmol/l) after long-term management | 1230 | 5450 | 23.3 | 3400 | 385 | <55 | Not done |
Renal and bladder USS | Normal | Normal | Normal | Normal | Normal | Normal | Normal |
RR, reference range (age appropriate); PRA, plasma renin activity; NA, not available; o.d., once daily; b.d., twice daily; q.d.s., four times daily; USS, ultrasound scan.
Doses subject to variation.